🇪🇺 Memantine (once daily) in European Union

EMA authorised Memantine (once daily) on 15 May 2002

Marketing authorisation

EMA — authorised 15 May 2002

  • Application: EMEA/H/C/000463
  • Marketing authorisation holder: H. Lundbeck A/S
  • Local brand name: Ebixa
  • Indication: Treatment of patients with moderate to severe Alzheimer's disease.
  • Status: approved

Read official source →

Other Neurology approved in European Union

Frequently asked questions

Is Memantine (once daily) approved in European Union?

Yes. EMA authorised it on 15 May 2002.

Who is the marketing authorisation holder for Memantine (once daily) in European Union?

H. Lundbeck A/S holds the EU marketing authorisation.